Biocidal Products Regulation (BPR)

EU framework governing approval of biocidal active substances and authorisation, labeling and market placing of biocidal products.

Foresight tracks Biocidal Products Regulation (BPR) developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.

Not ready for a trial? Take the 3-minute readiness assessment

Current activity

Intensifying

33% above the prior 8-week baseline

3-month trend

Latest alerts below

Last updated

24 May 2026, 20:45

View alerts

Latest Biocidal Products Regulation (BPR) developments

Source-backed regulatory and guidance signals tracked by Foresight, with the newest developments first.

EU Commission Makes Administrative Amendments to Union Authorisation for Taski‑Room Care‑Suma Lactic Acid Biocidal Family (Implementing Regulation (EU) 2026/700)

Commission Implementing Regulation (EU) 2026/700 introduces purely administrative amendments to the existing Union authorisation for the lactic-acid biocidal product family Taski-Room Care-Suma, updating the authorisation holder address and manufacturer details without changing the authorised uses or risk conclusions. Companies relying on this union authorisation face no new substantive obligations, but should ensure product labelling, regulatory records, and internal documentation reflect the revised holder and manufacturer information.

gazzettaufficiale.itEuropean UnionEuropean Union

EU Commission Requests ECHA Opinion On BCDMH Mutagenicity For Biocidal Product-Types 2, 11 And 12

The European Commission has asked ECHA’s Biocidal Products Committee to re-open its assessment of the active substance BCDMH for biocidal product-types 2, 11 and 12 by defining specific mutagenicity studies, allowing the applicant to submit new data, and revising earlier opinions that recommended non-approval due to a data gap. This re-evaluation could change whether BCDMH-based biocidal products can ultimately be approved in the EU, so active substance holders and formulators should closely track the new testing requirements, data deadlines, and any revised scientific opinions.

echa.europa.euEuropean UnionEuropean Union

EEA Joint Committee Decision 27/2026 Incorporates Implementing Decision 2025/1808 (Pythium oligandrum Strain M1) into Annex II to the EEA Agreement

Decision 27/2026 of the EEA Joint Committee, entering into force on 7 February 2026, amends Annex II to the EEA Agreement to incorporate EU Implementing Decision (EU) 2025/1808 on postponing the approval-expiry of Pythium oligandrum strain M1 under the Biocidal Products Regulation. This extends the EU biocides timeline for this active substance to the EEA EFTA countries, so manufacturers and users of product-type 10 biocidal products must align their renewal and authorisation planning with the longer approval period.

eur-lex.europa.euEuropean Economic AreaEuropean Economic Area

EU Adopts BPR Amendment Extending Certain Data Protection Periods To 2030

The EU has adopted an amendment to the Biocidal Products Regulation that extends data protection for certain active substance and product-type dossiers in the review programme until 31 December 2030 and creates a compensation right for data owners covering the unprotected period from 1 January 2026 to entry into force. Biocidal active substance suppliers and product authorisation holders should reassess data access and cost-sharing arrangements, as longer exclusivity and potential back claims may affect market access strategies, pricing, and negotiations with alternative suppliers through 2030.

data.consilium.europa.euEuropean UnionEuropean UnionEuropean Economic AreaEuropean Economic Area

ECHA Adds Peanut Butter (Arachis hypogaea L.) as PT19 Biocidal Active Substance Under BPR Assessment

In May 2026, ECHA added peanut butter (Arachis hypogaea L.) as a biocidal active substance for PT19 repellents and attractants under the EU Biocidal Products Regulation, with an initial application for approval now under BPC evaluation. This signals potential future EU-wide authorisation conditions or substitution-related constraints for peanut-based PT19 products, so manufacturers and applicants should track the BPC opinion and prepare data and portfolio strategies accordingly.

echa.europa.euEuropean UnionEuropean UnionSwitzerlandSwitzerland

Northern Ireland: Hydrogen Peroxide (PT12) No Longer Supported Under EU BPR, Non-Approval Decision Pending

ECHA’s biocides review programme list and an HSE ebulletin confirm that hydrogen peroxide (PT12) is no longer supported under the EU Biocidal Products Regulation, with an EU non-approval decision now pending that will apply in Northern Ireland once adopted. Biocidal product and treated article suppliers using hydrogen peroxide in PT12 for Northern Ireland should treat this as early warning to plan substitution and portfolio changes against the standard maximum 12- to 18-month BPR phase-out windows once the EU decision and concrete cut-off dates are published.

echa.europa.euEuropean UnionEuropean UnionUnited KingdomUnited Kingdom

EU Amends Union Authorisation for HYPRED Octanoic Acid Biocidal Product Family

The European Commission has adopted Implementing Regulation (EU) 2026/899, an official amendment to the Union authorisation for the HYPRED octanoic acid biocidal product family that is in force from mid-May 2026. The changes are administrative (trade names and manufacturing sites), so authorisation holders mainly need to update labels and internal records, with no apparent new use conditions, hazard profile, or expiry date impacts.

eur-lex.europa.euEuropean UnionEuropean Union

Biocides: Upcoming GB Active Substance Renewal Deadlines and Expiry Date

UK HSE has announced specific 550-day GB Biocidal Products Regulation renewal submission deadlines and an October 2026 expiry for certain active substance approvals, after which related biocidal products and treated articles can no longer be marketed in Great Britain. Companies relying on these active substances should urgently confirm who will support renewals, assess substitution or contingency options, and plan for potential product withdrawals as GB biocides policy and UK–EU SPS arrangements evolve.

content.govdelivery.comUnited KingdomUnited Kingdom

Netherlands Grants Emergency Exemption for Huwa-San TR-50 Use on MV Hondius

The Netherlands has issued an emergency decision allowing the hydrogen peroxide biocidal product Huwa‑San TR‑50 to be used by professional applicators on the ship MV Hondius to control a potential Andres-hantavirus infection, notwithstanding its normal authorisation limits. This narrow exemption shows how biocides approvals can be temporarily relaxed in public-health emergencies, but only under strict personal protective equipment and exposure monitoring conditions prescribed by Ctgb and the Biocidal Products Regulation.

zoek.officielebekendmakingen.nlNetherlandsNetherlands

EU Commission Postpones Medetomidine Approval Expiry for Biocidal Product-Type 21 Under BPR

The European Commission has registered an unpublished implementing decision (document C(2026)3192) to postpone the expiry date of the approval of medetomidine as an active substance for biocidal product-type 21 under the EU Biocidal Products Regulation. Although the new expiry date is not yet public, this signals that the approval period for medetomidine PT21 will be extended, so suppliers and users should track the forthcoming Official Journal text to understand how long the substance remains available and under what conditions.

ec.europa.euEuropean UnionEuropean Union

EU NGOs Comment On CLP Transfer ATP For EDC, PBT And vPvB Classifications

In April 2026, NGOs EEB and PAN Europe submitted comments on the EU CLP “transfer ATP” proposal to move existing endocrine disruptor and PBT/vPvB classifications for pesticides and biocides into Annex VI. They call for a shorter six-month transition period and for specific active substances to be (re)included, signalling stakeholder pressure to accelerate and broaden harmonised hazard communication under CLP, REACH, BPR and PPP.

circabc.europa.euEuropean UnionEuropean Union

EU Commission Adopts Delegated Regulation Annex Setting Exposure Limits for Carbon Dioxide in Biocidal Products Annex I Category 6

The European Commission has adopted the final annex to a delegated regulation under the Biocidal Products Regulation to restrict use of carbon dioxide as an active substance by imposing specific worker and by-stander exposure limits in Annex I Category 6. Once in force, these limits will govern authorisations of carbon dioxide-based biocidal products across the EU and require manufacturers and users to validate exposure scenarios and risk management measures against the new thresholds.

data.consilium.europa.euEuropean UnionEuropean Union

EU Commission Adopts Delegated Regulation Amending BPR Annex I Category 6 Restriction for Carbon Dioxide

In May 2026 the European Commission adopted a delegated regulation amending the Biocidal Products Regulation to revise the Annex I Category 6 restriction for carbon dioxide. The change replaces a narrow use condition with exposure-based limits for workers and the general public, meaning biocidal product authorisations using carbon dioxide must be reassessed and future applications designed to meet the new thresholds.

data.consilium.europa.euEuropean UnionEuropean Union

Portugal Comments on CLP Transfer ATP Harmonised Classifications

Portugal has filed detailed comments on the EU draft CLP Annex VI ‘Transfer ATP’, seeking multiple corrections to harmonised classifications for tributyltin compounds, nonylphenols and their ethoxylates, HBCDD, PFHpA salts, difethialone, quinoxyfen, cholecalciferol and related entries. If adopted, these revisions could change PBT/vPvB and endocrine disruptor flags, concentration limits and mixture-classification rules under CLP, so companies using these substances should monitor the final ATP text and prepare for potential label and safety data sheet updates.

circabc.europa.euEuropean UnionEuropean Union

Commission Delegated Regulation Amending Regulation (EU) No 528/2012: Restriction of Carbon Dioxide (Annex I, Category 6)

In May 2026 the European Commission registered a Commission Delegated Regulation that will amend the EU Biocidal Products Regulation to restrict the use of carbon dioxide as an Annex I Category 6 active substance. This signals that EU carbon-dioxide-based biocidal applications are moving towards tighter legal conditions, so companies placing CO2-based biocidal products on the market should prepare for possible changes to permitted uses and compliance obligations once final terms and dates are confirmed.

ec.europa.euEuropean UnionEuropean Union

EU / ECHA Updates BPR Review Programme List Of Notifications (22 April 2026)

ECHA’s latest “List of notifications” for the EU biocidal products review programme, prepared as of 22 April 2026, confirms continued support for hydrogen peroxide (PT 11) and chlorine dioxide (TCDO, PT 2 and 4) while flagging several other actives, including hydrogen peroxide (PT 12), TMAD, BIT, Terbutryn and ADBAC (C12–C14), for removal from the programme and subsequent non-approval. Biocidal active substance suppliers and product manufacturers using these chemistries now face a missed 6 March 2026 application deadline for hydrogen peroxide PT 12 and an 8 January 2027 deadline for the TCDO-based chlorine dioxide system, and should plan for substitution and phase-out where Commission non-approval decisions are expected.

echa.europa.euEuropean UnionEuropean Union

EU ECHA Updates R4BP Supporting Documents for Biocidal Products

The European Chemicals Agency has updated its R4BP supporting documents, publishing 2026 templates for Article 95 assets and Union authorisation applications under the Biocidal Products Regulation. These standardised forms underpin dossier completeness, so companies submitting or amending biocidal product applications should switch to the new templates immediately to avoid delays or rejection.

echa.europa.euEuropean UnionEuropean Union

ECHA Issues Administrative-Change Opinions for Three Biocidal Product Families

In mid-May 2026, the European Chemicals Agency issued new opinions on administrative changes to existing EU-wide biocidal product authorisations for the Ecolab Iodien PT3, Neporex 2SG and Airedale PAA product families. These opinions signal further fine-tuning of Union authorisation conditions under the Biocidal Products Regulation, so authorisation holders and downstream users should monitor forthcoming Commission decisions and be ready to adjust product labelling, uses and supply planning if required.

echa.europa.euEuropean UnionEuropean Union

EU Biocides Coordination Group Circulates Updated List of Active Substances Meeting Exclusion/Substitution Criteria (CG-69-2025-15)

The EU Biocides Coordination Group has circulated an updated list of active substances that meet the Biocidal Products Regulation’s exclusion or substitution criteria, with rapporteur Member States asked to validate the new information by early December 2025. Inclusion on this list signals higher regulatory scrutiny and potential substitution pressure, so companies using biocidal active substances should check the updated list once published to anticipate stricter approval or renewal conditions.

webgate.ec.europa.euEuropean UnionEuropean Union

ECHA Coordination Group Refers Revised RPE N-Sentences (N-71, N-9) For Human Health WG Review

ECHA’s Coordination Group has agreed draft changes to the standard respiratory protective equipment (RPE) and protective coverall “N-sentences” used in biocidal product authorisations and has sent the revised wording to the Human Health Working Group for further review. If finalised, these updates will tighten expectations on assigned protection factors, EN-standard-compliant PPE, and how applicants document worker protection measures in Union and mutual-recognition authorisations under the Biocidal Products Regulation.

webgate.ec.europa.euEuropean UnionEuropean Union

Not a newsletter. Not a feed. Structured intelligence mapped to your business.

These are just a few of the most recent Biocidal Products Regulation (BPR) alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.

Start free trial

Topic context

How to read Biocidal Products Regulation (BPR) regulatory activity

Definition

What is Biocidal Products Regulation (BPR)?

EU framework governing approval of biocidal active substances and authorisation, labeling and market placing of biocidal products.

Industry relevance

Why it matters

Biocidal Products Regulation (BPR) developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.

Foresight tracking

How Foresight monitors it

Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.

Frequently asked questions

Everything you need to know about Foresight's regulatory intelligence platform

Still have questions? Get in touch with our team

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX